VC  New Enterprise Associates

http://www.nea.com





     Office Locations:

2855 Sand Hill Road
Menlo Park, CA 94025
Phone: 650-854-9499
Fax: 650-854-9397

Get all office locations for this firm with a National Database subscription or New York Database subscription.
 

Stages:

  • Early
  • Growth
  • Seed


 

Industries:

  • Electronics & Advanced Materials
  • Energy & Clean Tech
  • Information Technology
  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Founded in 1978, NEA manages nearly $17 billion of committed capital across 15 funds. NEA has invested in 175 companies that have gone public and 290 that have successfully been merged or acquired. The firm concentrates on early stage companies in the areas of information technology, healthcare, and energy technology, typically investing in 20 to 30 new companies each year. NEA's first investment can range from $200,000 up to $40 million. NEA invests at all stages, but is especially interested in providing start-up capital, or the first outside funds a company raises. Although the majority of NEA's investments are in the United States, the firm invests internationally and is particularly interested in China and India. NEA announced (April 2015) the close of its fifteenth fund with $2.8 billion in committed capital to its core fund, as well as an additional $350 million for its NEA 15 Opportunity Fund.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Alex Kinnier Partner
    Ali Behbahani Partner
    C. Richard Kramlich Chairman & Co-Founder
    Carmen Chang Partner and Managing Director
    Carol Gallagher Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      01/03/2019


      Tiburio Therapeutics


      MA


      $31,000,000


      Series A


      12/27/2018


      sprout social


      IL


      $40,500,000


      Series D


      12/19/2018


      Annexon Biosciences


      CA


      $75,000,000


      Series C


      12/13/2018


      Tigera


      CA


      $30,000,000


      Series B


      12/06/2018


      Forethought


      CA


      $9,000,000


      Series A


      11/29/2018


      Bright Health


      MN


      $200,000,000


      Series C


      11/21/2018


      PlayVS


      CA


      $30,500,000


      


      11/20/2018


      Zero


      CA


      $16,000,000


      


      11/14/2018


      Mojo Vision


      CA


      $50,000,000


      


      11/07/2018


      Mirum Pharmaceuticals


      CA


      $120,000,000


      Series A


      10/26/2018


      DataRobot


      MA


      $100,000,000


      Series D


      10/25/2018


      InfoWorks


      CA


      $25,000,000


      Series C


      10/25/2018


      Wirewheel


      VA


      $10,000,000


      Series A


      10/22/2018


      Qpex Biopharma


      CA


      $33,000,000


      Series A


      10/05/2018


      OmniSci


      CA


      $55,000,000


      Series C


      09/28/2018


      Broadly


      CA


      $6,700,000


      Series A


      09/26/2018


      Forter


      CA


      $50,000,000


      Series D


      09/20/2018


      Galera Therapeutics


      PA


      $150,000,000


      Series C


      09/18/2018


      Enigma


      NY


      $95,000,000


      Venture


      09/13/2018


      Datrium


      CA


      $60,000,000


      Series D


      09/01/2018


      Tempus


      IL


      $110,000,000


      Series E


      08/24/2018


      Paladina Health


      CO


      $165,000,000


      Growth


      08/23/2018


      Sitetracker


      CA


      $24,000,000


      Venture


      08/07/2018


      Akouos


      MA


      $50,000,000


      Series A


     

    Portfolio companies include:


      Akouos
        web link


      Annexon Biosciences
        web link


      Bright Health


      Broadly
        web link


      DataRobot
        web link


      Datrium
        web link


      Enigma
        web link


      Forethought
        web link


      Forter
        web link


      Galera Therapeutics
        web link


      InfoWorks
        web link


      Mirum Pharmaceuticals
        web link


      Mojo Vision
        web link


      OmniSci
        web link


      Paladina Health
        web link


      PlayVS
        web link


      Qpex Biopharma


      Sitetracker
        web link


      sprout social
        web link


      Tempus
        web link


      Tiburio Therapeutics
        web link


      Tigera
        web link


      Wirewheel
        web link


      Zero
        web link


     

    Recent News: